Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5,800
Frequently Asked Questions
What is Market Cap of Moderna Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Moderna Inc market cap is $10.07B.
What is the 52-week high for Moderna Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Moderna Inc 52 week high is $67.96 as of September 25, 2025.
What is the 52-week low for Moderna Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Moderna Inc 52 week low is $23.15 as of September 25, 2025.
What is Moderna Inc stock price today?
Moderna Inc stock price today is $24.73.
What was Moderna Inc stock price yesterday?
Moderna Inc stock price yesterday was $25.88.
What is the PE ratio of Moderna Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Moderna Inc’s P/E ratio is -3.44.
What is the Price-to-Book ratio of Moderna Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Moderna Inc P/B ratio is 1.0711.
What is the 50-day moving average of Moderna Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Moderna Inc 50-day moving average is $27.36.